Assignee
BIOASIS TECHNOLOGIES INC
US·12 granted patents·15 pending applications·66 citations·filing 2013–2022
Top patents by PatentIndex Score
27 records- 0194US9364567B2Fragments of p97 and uses thereofBIOASIS TECHNOLOGIES INC·Filed 2014·Granted Jun 14, 2016·25 cites·25 claims
- 0293US9850472B2P97-antibody conjugates and methods of useBIOASIS TECHNOLOGIES INC·Filed 2015·Granted Dec 26, 2017·8 cites·14 claims
- 0391US10772939B2Fragments of P97 and uses thereofBIOASIS TECHNOLOGIES INC·Filed 2018·Granted Sep 15, 2020·3 cites·15 claims
- 0491US9993530B2Fragments of P97 and uses thereofBIOASIS TECHNOLOGIES INC·Filed 2016·Granted Jun 12, 2018·8 cites·11 claims
- 0587US9161992B2P97 fragments with transfer activityBIOASIS TECHNOLOGIES INC·Filed 2014·Granted Oct 20, 2015·13 cites·16 claims
- 0686US9932565B2Dephosphorylated lysosomal storage disease proteins and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2013·Granted Apr 3, 2018·7 cites·7 claims
- 0774US2020188522A1Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesBIOASIS TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 0870US10392605B2P97-IDS fusion proteinsBIOASIS TECHNOLOGIES INC·Filed 2015·Granted Aug 27, 2019·1 cites·20 claims
- 0969US11034943B2Dephosphorylated lysosomal storage disease proteins and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2018·Granted Jun 15, 2021·0 cites·8 claims
- 1069US10716862B2Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesBIOASIS TECHNOLOGIES INC·Filed 2017·Granted Jul 21, 2020·0 cites·3 claims
- 1169US2021388330A1Dephosphorylated lysosomal storage disease proteins and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1268US2020376092A1Fragments of p97 and uses thereofBIOASIS TECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 1367US10058619B2P97-polynucleotide conjugatesBIOASIS TECHNOLOGIES INC·Filed 2015·Granted Aug 28, 2018·1 cites·13 claims
- 1466US11124781B2P97-IDS fusion proteinsBIOASIS TECHNOLOGIES INC·Filed 2019·Granted Sep 21, 2021·0 cites·12 claims
- 1563US11643454B2P97 fusion proteinsBIOASIS TECHNOLOGIES INC·Filed 2019·Granted May 9, 2023·0 cites·3 claims
- 1662US2015093399A1Cns-targeted conjugates having modified fc regions and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 1754US2022048992A1Combination therapies for delivery across the blood brain barrierBIOASIS TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1854US2022144906A1Bifunctional blood brain therapies for interleukin-1 related diseasesBIOASIS TECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1954US2021393787A1Compositions and methods for treating frontotemporal dementiaBIOASIS TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2053US2021355468A1Compositions and methods for treating lewy body dementiaBIOASIS TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 2148US2019192683A1Cns-targeted conjugates having modified fc regions and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2017·Application pending·0 cites
- 2246US2021046149A1Bifunctional blood brain therapiesBIOASIS TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 2343US2019022244A1Blood-brain barrier vector compounds and conjugates thereofBIOASIS TECHNOLOGIES INC·Filed 2017·Application pending·0 cites
- 2443US2022162336A1Treatment of lymphatic metastasesBIOASIS TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 2542US2018009898A1Antibodies against p97 and conjugates thereofBIOASIS TECHNOLOGIES INC·Filed 2016·Application pending·0 cites
- 2642US2021113703A1Treatment of gaucher diseaseBIOASIS TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 2740US2016347821A1P97 fusion proteinsBIOASIS TECHNOLOGIES INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIOASIS TECHNOLOGIES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →